Browse > Article
http://dx.doi.org/10.22246/jikm.2020.41.3.447

Clinical Analysis of 60 Patients with Hepatocellular Cancer Treated in Korean Medicine Hospital; A Retrospective Chart Review  

Yoon, Mi-jung (Dept. of Korean Internal Medicine of Hepatology, College of Korean Medicine, Daegu Haany University)
Cho, Na-kyung (Dept. of Korean Internal Medicine of Hepatology, College of Korean Medicine, Daegu Haany University)
Choi, Hong-sic (Dept. of Korean Internal Medicine of Hepatology, College of Korean Medicine, Daegu Haany University)
Kim, Seung-mo (Dept. of Korean Internal Medicine of Hepatology, College of Korean Medicine, Daegu Haany University)
Kim, Sang-chan (Dept. of Herbal Formulation, College of Korean Medicine, Daegu Haany University)
Kim, Kyung-soon (Dept. of Korean Internal Medicine of Hepatology, College of Korean Medicine, Daegu Haany University)
Publication Information
The Journal of Internal Korean Medicine / v.41, no.3, 2020 , pp. 447-456 More about this Journal
Abstract
Objectives: This review aimed to present the characteristics of hepatocellular cancer patients treated by Korean medicine. Methods: Sixty hepatocellular cancer patients in a Korean medicine hospital from July 2012 to December 2019 were studied. We evaluated the general characteristics, overall therapies, and chief complaints of the patients. Results: Of the patients, 55% were stage IV, and Korean medicine was accompanied by conventional treatments, such as chemotherapy, operation, and transarterial chemoembolization. An average number of hepatocellular cancer patients had admitted to the hospital. The patients' chief complaints were dyspnea, general weakness, abdominal discomfort, and cancer-related pain. Conclusions: This study illustrates the general characteristics of hepatocellular cancer patients on Korean medicine treatments. These findings suggest that further investigations with a rigorous study design and more participants are needed.
Keywords
Korean medicine; hepatocellular carcinoma; cancer; clinical characteristics;
Citations & Related Records
Times Cited By KSCI : 12  (Citation Analysis)
연도 인용수 순위
1 Lee MN, Nam HJ, Lee SH, Kim WK, Ryu IC. The cause of Liver cancer, diagnosis and treatment trend. Biowave 2006;8(4):1-15.
2 https://www.g-health.kr/portal/bbs/selectBoardArticle.do?bbsId=U00322&nttId=381808&menuNo=200449&lang=&searchCndSj=&searchCndCt=&searchWrd=&pageIndex=1&vType=Z3
3 Ryu HS, Yoon SS, Lee JY, Yoon SW. Perspectives of Cancer Patients on Korean Medicine Treatments: A Cross-sectional Survey. J Int Korean Med 2017;38(3):319-26.   DOI
4 Cho NK, Lee YR, Kim KS, Choi HS, Kim SM. An Analysis of Clinical Characteristics for 226 Patients with Gastrointestinal Cancer Treated at a Korean Medicine Hospital: A Retrospective Chart Review. J Int Korean Med 2018;39(4):708-16.   DOI
5 Park SY, Kim JS, Jeong MY, Kim JH, Choi JH. The Clinical Study for Peripheral Facial Paralysis Treated with Herbal Stream Therapy. J Korean Med Ophthalmol Otolaryngol Dermatol 2014;27(4):131-40.   DOI
6 Kim KI, Lee HB, Park EK, Choi YJ, Kim DH, Jung HJ, et al. Clinical Assessment of 28 Patients with Cough Treated with Herbal Steam Therapy. Korean J Oriental Physiology & Pathology 2013;27(5):660-6.
7 Lee SH, Noh SH, Kim SY, Jang KY, Hwang PH. Hand-Foot syndrome induced by sorafenib, a multitargeted tyrosine kinase inhibitor, in a patient with advanced renal cell carcinoma. Korean Journal of Pediatrics 2009;52(1):119-23.   DOI
8 Korean Statistical Information Service. Available from: URL:http://kosis.kr/index/index.do
9 Jang WI, Seo YS, Kim MS, Kim HJ. Academic Trend and Clinical Status of Radiotherapy for Hepatobiliary Cancer Over the Past 20 Years in Korea. The Korean Liver Cancer Study Group 2015;15(2):100-5.
10 Kim JH. 2018 Korean Liver Cancer Association and National Cancer Center for Clinical Practice Guidelines of Hepatocellular Carcinoma: What's Different from 2014? Korean J Gastroenterol 2019;74(2):101-9.   DOI
11 Leung L, Winnie Y. Value of quality of life analysis in liver cancer: A clinician's perspective. World J Hepato 2017;9(20):867-83.   DOI
12 Kasper DL, Fauci AS, Hauser S, Longo D, Jameson L, Loscalzo J. Harrison's Principles of Internal Medicine 19th edition. Seoul: McGraw-Hill Education Korea; 2017, p. 887-96.
13 Park JG, Bang YJ, Ha SW. Oncology. Seoul: Ilchokak; 2012, p. 290-309, 339-52.
14 Wang JH, Shin JW, Cho JH, Cho CK, Yoo HS, Lee YW, et al. Study on Traditional Chinese Medicine against Liver Cancer. Daejeon University Oriental medicine journal 2006;15(2):159-68.
15 Thanawat W, Kanitta B, Health-Related Quality of Life as Measured by EQ-5D and TFLIC-2 in Liver Cancer Patients Siriraj Medical Journal 2018;70(5):406-12.
16 Chen F, Zhong Z, Tan HY, Guo W, Zhang C, Tan CW, et al. Uncovering the Anticancer Mechanisms of Chinese Herbal Medicine Formulas: Therapeutic Alternatives for Liver Cancer. Front Pharmacol 2020;11:293.   DOI
17 Riad S, Margaret G, Zeeshan B, Khairuddin M, Micheal V, Ryan H, et al. Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization. clinical gastroenterology and hepatology 2013;11(10):1358-65.   DOI
18 Gabriella M, Dawn L, Laura F, Zaixing S, Wei-Yann T, Heather G. Complementary and Alternative Medicine Use among US Cancer Survivors J Cancer Surviv 2016;10(5):850-64.   DOI
19 Han WJ, Lee EJ, Han GJ, Yoon SH, Han GJ, Leem JT. Effectiveness of comprehensive traditional Korean Medicine treatment on quality of life, anorexia and cachexia of cancer patients: Retrospective chart review. J Korean Med 2019;40(2):119-32.   DOI
20 Han GJ, Kim DH, Park EJ, Seong S, Kim SS, Leem JT. Analysis of Existing Guidelines and Randomized, Controlled, Clinical Trials for Development of [Guideline of Clinical Trial on Herbal Medicinal Product for Liver Cancer]. J Int Korean Med 2019;40(1):89-116.
21 Yoon SS, Ryu HS, Oh HK, Lee JY, Yoon SW. The Efficacy of Acupuncture for Postoperative Pain in Patients with Solid Tumor : A Systematic Review and Meta Analysis. J of Kor Traditional Oncology 2017;22(2):1-11.   DOI
22 Choi CM, Koh BH, Kim SH, Choi WC, Lee SK. A Study on Quality of Life of Advanced Hepatobiliary and Pancreatic Cancer patients Administered with Traditional Korean Cancer Treatment. J Korean Oriental Med 2008;29(4):30-8.
23 Choi YJ, Lee JS, Cho SH. Use of Korean Medicine among Cancer Patients. J Korean Oriental Med 2012;33(3):46-53.
24 Choi IS, Oh CH, Park SY, Ahn SE, Park SJ, Choi HR, et al. Incidence of Primary Liver Cancer in Subjects with Chronic Hepatitis B in Korean National Liver Cancer Screening Program. J Liver Cancer 2017;17(2):136-43.   DOI